Factors Associated With Failure of Metronidazole in Clostridium difficile-associated Disease

Journal of Clinical Gastroenterology

Volumn 38, Issue 5, 2004, Pages 414-418

  Fernandez, Angel ^a   Anand, Girish ^a   Friedenberg, Frank ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Albumin; Clostridium difficile; Intensive care unit; Metronidazole

Indexed keywords

ALBUMINOID; ANTIINFECTIVE AGENT; METRONIDAZOLE; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG EFFECT; FEMALE; HUMAN; LENGTH OF STAY; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; DIARRHEA; FEMALE; HUMANS; LENGTH OF STAY; MALE; METRONIDAZOLE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT FAILURE; VANCOMYCIN;

EID: 4344559215     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-200405000-00005     Document Type: Article

References (30)

1. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA. 1993;269:71-75.
2. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204-210.
3. Ambrose N. The effects of single doses of antibiotics on fecal flora with a reference to their mode of excretion. J Drug Dev. 1989;1:233-241.
4. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40:1-15.
5. Brown B, Talbot GH, Axelrod P, et al. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol. 1990;11:283-290.
6. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and Clostridium difficile associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162:678-684.
7. Djuretic T, Wall PG, Brazier JS. Clostridium difficile: An update on its epidemiology and role in hospital outbreaks in England and Wales. J Hosp Infect. 1999;41:213-218.
8. Kelly CP, LaMont JT. Clostridium difficile infection. Ann Rev Med. 1998;49:375-390.
9. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet. 1983;2:1043-1046.
10. Olson MM, Shanholtzer CJ, Lee JT Jr, et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol. 1994;15:371-381.
11. Zimmerman MJ, Bak A, Sutherland LR. Review Article: Treatment of Clostridium difficile infection. Aliment Pharmacol Ther. 1997;11:1003-1012.
12. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol. 1997;92:739-750.
13. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control. 1995;23:87-94.
14. Molavi A, LeFrock JL, Prince RA. Metronidazole. Med Clin North Am. 1982;66:121-133.
15. Friedenberg F, Fernandez A, Kaul V, et al. Intravenous metronidazole for the treatment of Clostridium difficile colitis. Dis Colon Rectum. 2001;44:1176-1180.
16. Kyne L, Farrell RJ, Kelly CP. Clostridium difficile. Gastro Clin N Amer. 2001;30:753-777.
17. Teasley DG, Olson MM, Gebhard RL, et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet. 1983;2:1444.
18. Wenisch C, Parschalk B, Hasenhundl M, et al. Comparison of vancomycin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis. 1996;22:813.
19. Brazier JS, Levett PN, Stannard KD, et al. Antibiotic susceptibility of clinical isolates of clostridia. J Antimicrob Chemother. 1985;15:181.
20. Drummond LJ, McCoubrey J, Smith DG, et al. Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric inpatients over an 18-month period. J Med Micro. 2003;52:259-263.
21. Barbut F, Decre D, Burghoffer B, et al. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agent Chemother. 1999;43:2607-2611.
22. Burdon DW, Brown JD, Youngs D, et al. Antibiotic susceptibility of Clostridium difficile. J Antimicrob Chemother. 1979;5:307.
23. Dzink JA, Bartlett JG. In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrob Agents Chemother. 1980;17:695.
24. Fekety R, Silva J, Kauffman C, et al. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: Comparison of two dosage regimens. Am J Med. 1989;86:15.
25. Shuttleworth R, Taylor M, Jones DM. Antimicrobial susceptibilities of Clostridium difficile. J Clin Pathol. 1980;33:1002.
26. Wong SSY, Woo PCY, Luk WK, et al. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest. Diagn Microbiol Infect Dis. 1999;34:1-6.
27. Nair S, Yadav D, Corpuz M, et al. Clostridium difficile colitis: factors influencing treatment failure and relapse—a prospective evaluation. Am J Gastroenterol. 1998;93:1873-1876.
28. Ramaswamy R, Grover H, Corpuz M. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol. 1996;91:460-464.
29. Liolios A, Oropello J, Benjamin E. Gastrointestinal complications in the intensive care unit. Clin Chest Med. 1999;20:329-345.
30. Kalb T, Lorin S. Infection in the chronically critically ill: unique risk profile in a newly defined population. Crit Care Clin. 2002;18:529-552.